These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20221896)

  • 1. The role of the intestinal lymphatics in the absorption of two highly lipophilic cholesterol ester transfer protein inhibitors (CP524,515 and CP532,623).
    Trevaskis NL; McEvoy CL; McIntosh MP; Edwards GA; Shanker RM; Charman WN; Porter CJ
    Pharm Res; 2010 May; 27(5):878-93. PubMed ID: 20221896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of lymphatic access of two cholesteryl ester transfer protein inhibitors (CP524,515 and CP532,623) and evaluation of their impact on lymph lipoprotein profiles.
    Trevaskis NL; Shanker RM; Charman WN; Porter CJ
    Pharm Res; 2010 Sep; 27(9):1949-64. PubMed ID: 20635194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different impacts of intestinal lymphatic transport on the oral bioavailability of structurally similar synthetic lipophilic cannabinoids: dexanabinol and PRS-211,220.
    Gershkovich P; Qadri B; Yacovan A; Amselem S; Hoffman A
    Eur J Pharm Sci; 2007 Aug; 31(5):298-305. PubMed ID: 17560096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic transport of Methylnortestosterone undecanoate (MU) and the bioavailability of methylnortestosterone are highly sensitive to the mass of coadministered lipid after oral administration of MU.
    White KL; Nguyen G; Charman WN; Edwards GA; Faassen WA; Porter CJ
    J Pharmacol Exp Ther; 2009 Nov; 331(2):700-9. PubMed ID: 19696095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A physicochemical basis for the extensive intestinal lymphatic transport of a poorly lipid soluble antimalarial, halofantrine hydrochloride, after postprandial administration to dogs.
    Khoo SM; Prankerd RJ; Edwards GA; Porter CJ; Charman WN
    J Pharm Sci; 2002 Mar; 91(3):647-59. PubMed ID: 11920750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of intestinal lymphatic transport on the systemic exposure and brain deposition of a novel highly lipophilic compound with structural similarity to cholesterol.
    Caliph SM; Faassen FW; Porter CJ
    J Pharm Pharmacol; 2014 Oct; 66(10):1377-87. PubMed ID: 24821499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel, non-tetrahydroquinoline variant of the cholesteryl ester transfer protein (CETP) inhibitor torcetrapib, with improved aqueous solubility.
    Kalgutkar AS; Frederick KS; Hatch HL; Ambler CM; Perry DA; Garigipati RS; Chang GC; Lefker BA; Clark RW; Morehouse LA; Francone O; Hu X
    Xenobiotica; 2014 Jul; 44(7):591-605. PubMed ID: 24380613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a self-emulsifying formulation that reduces the food effect for torcetrapib.
    Perlman ME; Murdande SB; Gumkowski MJ; Shah TS; Rodricks CM; Thornton-Manning J; Freel D; Erhart LC
    Int J Pharm; 2008 Mar; 351(1-2):15-22. PubMed ID: 18024021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor.
    Hauss DJ; Fogal SE; Ficorilli JV; Price CA; Roy T; Jayaraj AA; Keirns JJ
    J Pharm Sci; 1998 Feb; 87(2):164-9. PubMed ID: 9519148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs.
    Shackleford DM; Faassen WA; Houwing N; Lass H; Edwards GA; Porter CJ; Charman WN
    J Pharmacol Exp Ther; 2003 Sep; 306(3):925-33. PubMed ID: 12807999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the acyl coenzyme A:cholesterol acyl transferase inhibitor CP-105,191 in dogs--the effect of food and sesame oil on systemic exposure following oral dosing.
    Inskeep PB; Davis KM; Reed AE
    J Pharm Sci; 1995 Feb; 84(2):131-3. PubMed ID: 7738788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral bioavailability assessment and intestinal lymphatic transport of Org 45697 and Org 46035, two highly lipophilic novel immunomodulator analogues.
    Caliph SM; Faassen WA; Vogel GM; Porter CJ
    Curr Drug Deliv; 2009 Aug; 6(4):359-66. PubMed ID: 19534711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal lymphatic transport enhances the post-prandial oral bioavailability of a novel cannabinoid receptor agonist via avoidance of first-pass metabolism.
    Trevaskis NL; Shackleford DM; Charman WN; Edwards GA; Gardin A; Appel-Dingemanse S; Kretz O; Galli B; Porter CJ
    Pharm Res; 2009 Jun; 26(6):1486-95. PubMed ID: 19280324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of lymphatic transport to the systemic exposure of orally administered moxidectin in conscious lymph duct-cannulated dogs.
    Lespine A; Chanoit G; Bousquet-Melou A; Lallemand E; Bassissi FM; Alvinerie M; Toutain PL
    Eur J Pharm Sci; 2006 Jan; 27(1):37-43. PubMed ID: 16198549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems.
    Wu H; Zhou A; Lu C; Wang L
    Eur J Pharm Sci; 2011 Mar; 42(4):348-53. PubMed ID: 21216284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of lymphatic transport on the systemic bioavailability of the Bcl-2 protein family inhibitors navitoclax (ABT-263) and ABT-199.
    Choo EF; Boggs J; Zhu C; Lubach JW; Catron ND; Jenkins G; Souers AJ; Voorman R
    Drug Metab Dispos; 2014 Feb; 42(2):207-12. PubMed ID: 24212376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs.
    Khoo SM; Shackleford DM; Porter CJ; Edwards GA; Charman WN
    Pharm Res; 2003 Sep; 20(9):1460-5. PubMed ID: 14567642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the impact of drug properties on the extent of intestinal lymphatic transport - in vitro and in vivo studies.
    Lawless E; Griffin BT; O'Mahony A; O'Driscoll CM
    Pharm Res; 2015 May; 32(5):1817-29. PubMed ID: 25428258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intestinal lymphatic transport of breviscapine orally administered in rat].
    Gong YJ; Wang JX; Zhang Y; Shen M; Fu CM; Shen T
    Yao Xue Xue Bao; 2011 Oct; 46(10):1262-7. PubMed ID: 22242462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80.
    Lind ML; Jacobsen J; Holm R; Müllertz A
    Eur J Pharm Sci; 2008 Oct; 35(3):211-8. PubMed ID: 18675904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.